These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29345289)

  • 1. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-responsive sites in normal and malignant human lung tissues.
    Yasuda Y; Hara S; Hirohata T; Koike E; Yamasaki H; Okumoto K; Hoshiai H
    Anat Sci Int; 2010 Dec; 85(4):204-13. PubMed ID: 20397063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
    Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR
    Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of erythropoietin receptor expression in malignant melanoma.
    Mirmohammadsadegh A; Marini A; Gustrau A; Delia D; Nambiar S; Hassan M; Hengge UR
    J Invest Dermatol; 2010 Jan; 130(1):201-10. PubMed ID: 19536148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
    Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
    Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
    Sakamoto H; Kitamura T; Yoshimura A
    J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.
    Miyake M; Goodison S; Lawton A; Zhang G; Gomes-Giacoia E; Rosser CJ
    J Hematol Oncol; 2013 Sep; 6():65. PubMed ID: 24004818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells.
    Merkle R; Steiert B; Salopiata F; Depner S; Raue A; Iwamoto N; Schelker M; Hass H; Wäsch M; Böhm ME; Mücke O; Lipka DB; Plass C; Lehmann WD; Kreutz C; Timmer J; Schilling M; Klingmüller U
    PLoS Comput Biol; 2016 Aug; 12(8):e1005049. PubMed ID: 27494133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
    Chan KK; Matchett KB; Coulter JA; Yuen HF; McCrudden CM; Zhang SD; Irwin GW; Davidson MA; Rülicke T; Schober S; Hengst L; Jaekel H; Platt-Higgins A; Rudland PS; Mills KI; Maxwell P; El-Tanani M; Lappin TR
    Oncotarget; 2017 Jun; 8(24):38251-38263. PubMed ID: 28418910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.
    Mohyeldin A; Lu H; Dalgard C; Lai SY; Cohen N; Acs G; Verma A
    Neoplasia; 2005 May; 7(5):537-43. PubMed ID: 15967106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
    Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
    Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
    Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
    Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
    Kumar SM; Yu H; Fong D; Acs G; Xu X
    Melanoma Res; 2006 Aug; 16(4):275-83. PubMed ID: 16845323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
    Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
    J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
    Wu P; Zhang N; Wang X; Zhang C; Li T; Ning X; Gong K
    PLoS One; 2012; 7(9):e45122. PubMed ID: 23028796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
    Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
    Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.